Daitoku Sakamuro

Associate Professor

Daitoku Sakamuro

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Biochemistry and Molecular Biology

The Graduate School

Department of The Graduate School


I obtained a Ph.D. degree at Osaka Univ. in biochemistry and cancer (Prof. N. Taniguchi) and was trained as a postdoc at Wistar Inst In molecular genetics (Dr. G.C. Prendergast).


  • Ph.D., Physiology, General Osaka University, 1991

  • MS, Biochemistry Nagoya University, 1986

  • BS, Biochemistry Nagoya University, 1984

Awards & Honors

  • 2011 Biotech (BIO) Humanitarian Award nominee 2011

  • The LCRC Special Award Cancer-Related Research Article Published in a Journal with the Highest Impact, 2011

  • The Chancellor’s Notes 2011

  • The Best Grant Proposal Award Stanley S. Scott Cancer Center, 2010

Courses Taught Most Recent Academic Year

  • MEDI 6220

  • MEDI 6240

  • BCMB 9010

    Seminar in BMB
  • BIOM 8021

    Biochem & Gene Regulation
  • BCMB 8340

    Elements of Scientific Pres
  • MEDI 6120

    Foundations of Medicine
  • MEDI 6130


Teaching Interests

I am interested in mentoring young talented minds in a research laboratory and also lecturing undergraduate/graduate levels in didactic courses by asking and discussing lots of intellectually challenging questions.


Selected Recent Publications

  • Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination, 2022
    Journal Article, Academic Journal
  • New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors, 2021
    Journal Article, Academic Journal
  • c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistanc, 2015
  • Restoration of tumor-suppressor functions by small molecule inhibitors, 2015
  • Role of BIN1 in double-stranded DNA break repair, 2015

Research Interests

I am interested in the mechanisms through which cancer cells acquire resistance to genotoxic stresses. An ultimate goal is to establish a strategy to enhance therapeutic benefits of conventional chemotherapy.

Professional Service

  • Scientifica (Cell Biology) 2012 - Present

    Role: Other
  • Apoptosis 1999 - Present

    Role: Reviewer, Ad Hoc Reviewer
  • BBA (Gene Structure & Expression) 1999 - Present

    Role: Reviewer, Ad Hoc Reviewer
  • Cancer Research 1999 - Present

    Role: Reviewer, Ad Hoc Reviewer
  • CANCER 1999 - Present

    Role: Reviewer, Ad Hoc Reviewer